Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer

Bayne, Lauren J., Beatty, Gregory L., Jhala, Nirag, Clark, Carolyn E., Rhim, Andrew D., Stanger, Ben Z., Vonderheide, Robert H.·2012·Cancer Cell

Cited by (952)

Items 101–200 of 952

  1. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
    Chunwan Lu, Amy V. Paschall, Huidong Shi, Natasha M. Savage, Jennifer L. Waller, Maria Eugenia Sabbatini, Nicholas H. Oberlies, Cedric J. Pearce, Kebin Liu · 2016 · JNCI Journal of the National Cancer Institute
  2. Cancer and inflammation
    Lance L. Munn · 2016 · WIREs Systems Biology and Medicine
  3. Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
    Yaqing Zhang, Wei Yan, Meredith A. Collins, Filip Bednar, Sabita Rakshit, Bruce R. Zetter, Ben Z. Stanger, Ivy Chung, Andrew D. Rhim, Marina Pasca di Magliano · 2013 · Cancer Research
  4. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
    Regina Jitschin, Martina Braun, Maike Büttner, Katja Dettmer‐Wilde, Juliane Bricks, Jana Berger, Michael Josef Eckart, Stefan W. Krause, Peter Josef Oefner, Katarina Le Blanc et al. · 2014 · Blood
  5. Inducers of immunogenic cancer cell death
    Aleksandra M. Dudek, Abhishek Dinkarnath Garg, Dmitri V. Krysko, Dirk De Ruysscher, Patrizia Agostinis · 2013 · Cytokine & Growth Factor Reviews
  6. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
    Albrecht Neeße, Kristopher K. Frese, Tashinga E. Bapiro, Tomoaki Nakagawa, Mark D. Sternlicht, Todd W. Seeley, Christian P. Pilarsky, Duncan Ian Jodrell, Suzanne M. Spong, David A. Tuveson · 2013 · Proceedings of the National Academy of Sciences
  7. CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
    Timothy Chao, Emma Elizabeth Furth, Robert H. Vonderheide · 2016 · Cancer Immunology Research
  8. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
    Wei Wang, Jill M. Marinis, Allison M. Beal, Shivraj Savadkar, Yue Wu, Mohammed Khan, Pardeep S. Taunk, Nan Wu, Wenyu Su, Jingjing Wu et al. · 2018 · Cancer Cell
  9. Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
    Chenhao Zhou, Zewen Kelvin Tuong, Ian Hector Frazer · 2019 · Frontiers in Oncology
  10. The Immune Microenvironment in Pancreatic Cancer
    Magdalena Huber, Corinna U. Brehm, Thomas Mathias Gress, Malte Buchholz, Bilal Alashkar Alhamwe, Elke Pogge von Strandmann, Emily P. Slater, Jörg Walter Bartsch, Christian Alexander Bauer, Matthias Lauth · 2020 · International Journal of Molecular Sciences
  11. Molecular Pathogenesis of Pancreatic Cancer
    Grant, T.J., Hua, K., Singh, A. · 2016 · Progress in Molecular Biology and Translational Science
  12. Current and future immunotherapeutic approaches in pancreatic cancer treatment
    Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, Ali‐Akbar Delbandi · 2024 · Journal of Hematology & Oncology
  13. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
    Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu, Nobufumi Sekino, Nami Kim, Theresa D. Manz, Benika J. Pinch, Dipikaa Akshinthala, Ana Verma, Giorgio Gaglia et al. · 2021 · Cell
  14. On the origin of myeloid-derived suppressor cells
    Camilla Rydberg Millrud, Caroline Bergenfelz, Karin Leandersson · 2016 · Oncotarget
  15. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
    Jiaqiao Fan, Mengfei Wang, Hailong Chen, Dong Shang, Jugal Kishore Das, Jianxun Jim Song · 2020 · Molecular Cancer
  16. Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
    Rachel A. Burga, Mitchell Thorn, Gary R. Point, Prajna Guha, Cang T. Nguyen, Lauren A. Licata, Ronald P. DeMatteo, Alfred Ayala, N. Joseph Espat, Richard Paul Junghans et al. · 2015 · Cancer Immunology Immunotherapy
  17. Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
    Yongwoo David Seo, Xiuyun Jiang, Kevin M. Sullivan, Florencia G. Jalikis, Kimberly S. Smythe, Arezou Abbasi, Marissa Vignali, James Oh Park, Sara K. Daniel, Seth M. Pollack et al. · 2019 · Clinical Cancer Research
  18. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
    Stefanie Riesenberg, Angela Groetchen, Robert Siddaway, Tobias Bald, Julia Reinhardt, Denise Smorra, Judith D. Sirokay, Marcel Renn, Bengt Phung, Pia Aymans et al. · 2015 · Nature Communications
  19. Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
    Kyoung Eun Lee, Michelle Spata, Lauren J. Bayne, Elizabeth L. Buza, Amy C. Durham, David Allman, Robert H. Vonderheide, Marie Celeste Simon · 2015 · Cancer Discovery
  20. Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
    Ralph Francescone, Debora Barbosa Vendramini Costa, Janusz Franco‐Barraza, Jessica Wagner, Alexander Muir, Allison N. Lau, Linara Gabitova, Tatiana Pazina, Sapna Gupta, Tiffany Luong et al. · 2020 · Cancer Discovery
  21. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
    Liyang Fei, Xiaochen Ren, Haijia Yu, Yifan Zhan · 2021 · Frontiers in Immunology
  22. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
    Dey, Prasenjit, Li, Jun, Zhang, Jianhua, Chaurasiya, Surendra, Strom, Anders, Wang, Huamin, Liao, Wen-Ting, Cavallaro, Frederick, Denz, Parker, Bernard, Vincent et al. · 2020 · Cancer Discovery
  23. Cytokines in cancer
    Courtney T. Stump, Stephanie K. Dougan · 2024 · Cancer Cell
  24. Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function
    Merav E. Shaul, Zvi Gregorio Fridlender · 2018 · FEBS Journal
  25. STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
    Weiqing Jing, Donna M. McAllister, Emily P. Vonderhaar, Katie A. Palen, Matthew John Riese, Jill A. Gershan, Bryon D. Johnson, Michael B. Dwinell · 2019 · Journal for ImmunoTherapy of Cancer
  26. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
    Melissa A. Meyer, John M. Baer, Brett L. Knolhoff, Timothy M. Nywening, Roheena Z. Panni, Xinming Su, Katherine N. Weilbaecher, William G. Hawkins, Cynthia X. Ma, Ryan Courtney Fields et al. · 2018 · Nature Communications
  27. Yes-Associated Protein Mediates Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
    S. Murakami, D. Shahbazian, R. Surana, Wei-Ying Zhang, Hengye Chen, G. Graham, Shannon M. White, L. Weiner, Chun-Ling Yi · 2016 · Oncogene
  28. Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
    Roheena Z. Panni, Dominic E. Sanford, Brian A. Belt, Jonathan B. Mitchem, Lori A. Worley, Brian D. Goetz, Pinku Mukherjee, Andrea Wang‐Gillam, Daniel C. Link, David G. DeNardo et al. · 2014 · Cancer Immunology Immunotherapy
  29. KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment
    Dias Carvalho, Patrícia, Guimarães, Carlos F., Cardoso, Ana P., Mendonça, Susana, Costa, Ângela M, Oliveira, Maria J., Velho, Sérgia · 2018 · Cancer Research
  30. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
    Matthew Dysthe, Robin Parihar · 2020 · Advances in experimental medicine and biology
  31. MicroRNA regulons in tumor microenvironment
    Hiroshi I. Suzuki, Akihiro Katsura, Hironori Matsuyama, Kohei Miyazono · 2014 · Oncogene
  32. Mice That Express Human Interleukin-8 Have Increased Mobilization of Immature Myeloid Cells, Which Exacerbates Inflammation and Accelerates Colon Carcinogenesis
    Samuel Asfaha, Alexander N. Dubeykovskiy, Hiroyuki Tomita, Xiangdong Yang, Sarah Stokes, Wataru Shibata, Richard A. Friedman, Hiroshi Ariyama, Zinaida A. Dubeykovskaya, Sureshkumar Muthupalani et al. · 2012 · Gastroenterology
  33. Immunotherapy for Breast Cancer: What Are We Missing?
    Vonderheide, Robert H., Domchek, Susan M., Clark, Amy S. · 2017 · Clinical Cancer Research
  34. Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model ( LSL‐Kras G12D/+ ;LSL‐Trp53 R172H/+ ;Pdx‐1‐Cre ), Its Variants, and Their Application in Immuno‐oncology Drug Discovery
    Jae Woo Lee, Chad A. Komar, Fee Bengsch, Kathleen L. Graham, Gregory Lawrence Beatty · 2016 · Current Protocols in Pharmacology
  35. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
    Sara K. Daniel, Kevin M. Sullivan, Kevin P. Labadie, Venu Gopal Pillarisetty · 2019 · Clinical and Translational Medicine
  36. Regulation and modulation of antitumor immunity in pancreatic cancer
    Joshua Leinwand, George Miller · 2020 · Nature Immunology
  37. Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
    Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, Roland Rad, Marc Schmidt‐Supprian, Dieter Saur · 2023 · Cancer Discovery
  38. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments
    Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, David Kilian, Hong Shi, Sapna Yadavilli, Yuliya V. Katlinskaya, Heather Kaczynski, Michael Conner, William Benson et al. · 2018 · PLoS ONE
  39. The immune network in pancreatic cancer development and progression
    Sonja M. Wörmann, Kalliope Nina Diakopoulos, Marina Lesina, Hana Algül · 2013 · Oncogene
  40. In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras -Mutant Lung Adenocarcinoma
    Fei Li, Qingyuan Huang, Troy A. Luster, Hai Hu, Hua Zhang, Wai‐Lung Ng, Alireza Khodadadi‐Jamayran, Wei Wang, Ting Chen, Jiehui Deng et al. · 2019 · Cancer Discovery
  41. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies
    Roheena Z. Panni, John M. Herndon, Chong Zuo, Samarth Hegde, Graham D. Hogg, Brett L. Knolhoff, Marcus A. Breden, Xiaobo Li, Varintra E. Krisnawan, Samia Q. Khan et al. · 2019 · Science Translational Medicine
  42. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
    Elisabeth Heßmann, Melanie S. Patzak, Lukas Klein, NM Chen, Vijayalakshmi Kari, Iswarya Ramu, Tashinga E. Bapiro, Kristopher K. Frese, Aarthi Gopinathan, Frances M. Richards et al. · 2017 · Gut
  43. T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma
    Ingunn M. Stromnes, Thomas M. Schmitt, Ayaka Hulbert, J. Scott Brockenbrough, Hieu Nguyen, Carlos Mario Cuevas, Ashley Dotson, Xiaoxia Tan, Jennifer L. Hotes, Philip D. Greenberg et al. · 2015 · Cancer Cell
  44. Inflammatory networks and immune surveillance of pancreatic carcinoma
    Robert H. Vonderheide, Lauren J. Bayne · 2013 · Current Opinion in Immunology
  45. T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma
    Ingunn M. Stromnes, Ayaka Hulbert, Robert Hamilton Pierce, Philip D. Greenberg, Sunil R. Hingorani · 2017 · Cancer Immunology Research
  46. GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer
    Meghna Waghray, Malica Yalamanchili, Michele L. Dziubinski, Mina Zeinali, Marguerite Erkkinen, Huibin Yang, Kara A. Schradle, Sumithra Urs, Marina Pasca di Magliano, Theodore Hobart Welling et al. · 2016 · Cancer Discovery
  47. Immune Resistance in Lung Adenocarcinoma
    Μάγδα Σπέλλα, Georgios T. Stathopoulos · 2021 · Cancers
  48. Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
    Chong Wu, Huiheng Ning, Mingyu Liu, Jie Lin, Shufeng Luo, Wenjie Zhu, Xu Jing, Wen-Chao Wu, Jing Liang, Chun‐Kui Shao et al. · 2018 · Journal of Clinical Investigation
  49. Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model
    Kuen, Janina, Darowski, Diana, Kluge, Tobias, Majety, Meher · 2017 · PLOS ONE
  50. Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
    Yumeng Mao, Isabel C. Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyhazi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Valentino Masucci, Andreas Lundqvist, Rolf W. Kiessling · 2013 · Cancer Research
  51. Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
    Daoxiang Zhang, Lin Li, Hongmei Jiang, Qiong Li, Andrea Wang‐Gillam, Jinsheng Yu, Richard Head, Jingxia Liu, Marianna B. Ruzinova, Kian‐Huat Lim · 2018 · Cancer Research
  52. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
    Rosalinda Trovato, Alessandra Fiore, Sara Sartori, Stefania Canè, Rosalba Giugno, Luciano Cascione, Salvatore Paiella, Roberto Salvia, Francesco De Sanctis, Ornella Poffe et al. · 2019 · Journal for ImmunoTherapy of Cancer
  53. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
    Recouvreux, Maria Victoria, Moldenhauer, Matthew R., Galenkamp, Koen M.O., Jung, Michael, James, Brian, Zhang, Yijuan, Lowy, Andrew, Bagchi, Anindya, Commisso, Cosimo · 2020 · Journal of Experimental Medicine
  54. Inflammatory outcomes of apoptosis, necrosis and necroptosis
    Pavel B. Davidovich, Conor J. Kearney, Séamus J. Martin · 2014 · Biological Chemistry
  55. The Pancreatic Cancer Microenvironment
    Stephanie K. Dougan · 2017 · The Cancer Journal
  56. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
    Yinan Deng, Jintao Cheng, Binsheng Fu, Wen Liu, Guangzi Chen, Qi Zhang, Yuebo Yang · 2016 · Oncogene
  57. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
    Tamar G. Kapanadze, Jaba Gamrekelashvili, Chi Ma, Carmen Chan, Fei Zhao, Stephen M. Hewitt, Lars Zender, Veena Kapoor, Dean W. Felsher, Michael Peter Manns et al. · 2013 · Journal of Hepatology
  58. The roles of CSF s on the functional polarization of tumor‐associated macrophages
    Pascale Jeannin, Léa Paolini, Clément Adam, Yves Delneste · 2017 · FEBS Journal
  59. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen
    Rebecca A. Evans, Mark S. Diamond, Andrew J. Rech, Timothy Chao, Max W. Richardson, Jeffrey Lin, David Lawrence Bajor, Katelyn T. Byrne, Ben Z. Stanger, James L. Riley et al. · 2016 · JCI Insight
  60. Genetically engineered mouse models of pancreatic adenocarcinoma
    Carmen E. Guerra, Mariano Barbacid · 2013 · Molecular Oncology
  61. Arginase 1 is a key driver of immune suppression in pancreatic cancer
    Rosa Elena Menjivar, Zeribe C. Nwosu, Wenting Du, Katelyn L. Donahue, Hanna S. Hong, Carlos E. Espinoza, Kristee L. Brown, Ashley Velez-Delgado, Wei Yan, Fatima Lima et al. · 2023 · eLife
  62. Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
    Jeffrey H. Lin, Austin P. Huffman, Max Miller Wattenberg, David M. Walter, Erica L. Carpenter, David M. Feldser, Gregory Lawrence Beatty, Emma Elizabeth Furth, Robert H. Vonderheide · 2020 · The Journal of Experimental Medicine
  63. The stromal compartments in pancreatic cancer: Are there any therapeutic targets?
    Serena Lunardi, Ruth J. Muschel, Thomas Baptist Brunner · 2013 · Cancer Letters
  64. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
    Qian Song, Jun Shang, Zuyi Yang, Lanlin Zhang, Chufan Zhang, Jianing Chen, Xianghua Wu · 2019 · Journal of Translational Medicine
  65. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
    Julianna Blagih, Fabio Zani, Probir Chakravarty, Marc Hennequart, Steven E. Pilley, Sebastijan Hobor, Andreas K. Hock, Josephine B. Walton, Jennifer P. Morton, Eva Camilla Gronroos et al. · 2020 · Cell Reports
  66. Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
    Nune Markosyan, Jinyang Li, Yu Huining Sun, Lee P. Richman, Jeffrey H. Lin, Fangxue Yan, Liz Quinones, Yogev Sela, Taiji Yamazoe, Naomi Gordon et al. · 2019 · Journal of Clinical Investigation
  67. Pancreatic Cancer, Inflammation, and Microbiome
    Constantinos Pantelis Zambirinis, Smruti Pushalkar, Deepak B. Saxena, George Miller · 2014 · The Cancer Journal
  68. Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
    Samuel I. Kim, Christopher R. Cassella, Katelyn T. Byrne · 2021 · Frontiers in Immunology
  69. Tumour-associated macrophages and cancer
    Jenny Anne Cook, Thorsten Hagemann · 2013 · Current Opinion in Pharmacology
  70. Host Immune Response to Infection and Cancer: Unexpected Commonalities
    Romina S. Goldszmid, Amiran Dzutsev, Giorgio Trinchieri · 2014 · Cell Host & Microbe
  71. Strategies for Increasing Pancreatic Tumor Immunogenicity
    Burles Avner Johnson, Mark M. Yarchoan, Valerie Lee, Daniel A. Laheru, Elizabeth M. Jaffee · 2017 · Clinical Cancer Research
  72. Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
    MacLean S. Hall, Hao Liu, Mokenge Peter Malafa, Barbara Ann Centeno, Pamela Joy Hodul, José M. Pimiento, Shari Pilon‐Thomas, Amod A. Sarnaik · 2016 · Journal for ImmunoTherapy of Cancer
  73. Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth
    Sounik Saha, Xunhao Xiong, Prabir Kumar Chakraborty, Khader Shameer, Rochelle R. Arvizo, Rachel A. Kudgus, Shailendra Kumar Dhar Dwivedi, Md. Nazir Hossen, Elizabeth M. Gillies, J. David Robertson et al. · 2016 · ACS Nano
  74. Myeloid cell heterogeneity in cancer: not a single cell alike
    Kiss, Mate, Van Gassen, Sofie, Movahedi, Kiavash, Saeys, Yvan, Laoui, Damya · 2018 · Cellular Immunology
  75. Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
    Sara A. Väyrynen, Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams, Vicente Morales‐Oyarvide, Mai Chan Lau, Douglas Adam Rubinson, Richard Francis Dunne et al. · 2020 · Clinical Cancer Research
  76. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
    Carlos A. Orozco, Neus Martínez‐Bosch, Pedro Enrique Guerrero, Judith Vinaixa, Tomás Dalotto‐Moreno, Mar Iglesias, Mireia Moreno, Magdolna Djurec, Françoise Poirier, Hans‐Joachim Gabius et al. · 2018 · Proceedings of the National Academy of Sciences
  77. Immune suppression and reversal of the suppressive tumor microenvironment
    Kanako Shimizu, Tomonori Iyoda, Masahiro Okada, Satoru Yamasaki, Shin‐ichiro Fujii · 2018 · International Immunology
  78. Mechanisms of T-Cell Exhaustion in Pancreatic Cancer
    Didem Saka, Muazzez Gökalp, Betül Piyade, Nedim Can Çevik, Elif Arik Sever, Derya Unutmaz, Guralp Onur Ceyhan, İhsan Ekin Demir, Hande Asimgil · 2020 · Cancers
  79. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
    Carole Siret, Aurélie Collignon, Françoise Silvy, Stéphane Robert, Thierry Cheyrol, Perrine André, Véronique Rigot, Juan Iovanna, Serge A. van de Pavert, Dominique Lombardo et al. · 2020 · Frontiers in Immunology
  80. N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology
    Benedict Boateng Antuamwine, Rebeka Bosnjakovic, Francisca Hofmann-Vega, Xi Wang, Θεοδόσιος Θεοδοσίου, Ioannis Iliopoulos, Sven Brandau · 2022 · Immunological Reviews
  81. Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
    Jonathan Ellermeier, Jiwu Wei, Peter Duewell, Sabine Hoves, Mareike R. Stieg, Tina Adunka, Daniel Noerenberg, Hans‐Joachim Anders, Doris Cooper Mayr, Hendrik Poeck et al. · 2013 · Cancer Research
  82. High-Fat, High-Calorie Diet Promotes Early Pancreatic Neoplasia in the Conditional KrasG12D Mouse Model
    David W. Dawson, Kathleen M. Hertzer, Aune Moro, Graham W. Donald, Hui-Hua Chang, Vay Liang W. Go, S. J. Pandol, Aurelia Lugea, Anna S. Gukovskaya, Gang Li et al. · 2013 · Cancer Prevention Research
  83. Stromal cues regulate the pancreatic cancer epigenome and metabolome
    Sherman, Mara H., Yu, Ruth T., Tseng, Tiffany W., Sousa, Cristovao M., Liu, Sihao, Truitt, Morgan L., He, Nanhai, Ding, Ning, Liddle, Christopher, Atkins, Annette R. et al. · 2017 · Proceedings of the National Academy of Sciences
  84. Myeloid-Derived Suppressor Cells Play Crucial Roles in the Regulation of Mouse Collagen-Induced Arthritis
    Wataru Fujii, Eishi Ashihara, Hideyo Hirai, Hidetake Nagahara, Naoko Kajitani, Kazuki Fujioka, Ken Murakami, Takahiro Seno, Aihiro Yamamoto, Hidetaka Ishino et al. · 2013 · The Journal of Immunology
  85. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology
    Hanxiang Zhan, Bin Zhou, Yugang Cheng, Jianwei Xu, Lei Wang, Guangyong Zhang, Sanyuan Hu · 2017 · Cancer Letters
  86. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
    Douglas E. Biancur, Alec C. Kimmelman · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  87. Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma
    Kianna Y. Elahi-Gedwillo, Marjorie Carlson, Jon Zettervall, Paolo P. Provenzano · 2018 · Cancer Research
  88. Tumor microenvironment for cancer stem cells
    Kazuyoshi Kise, Yumi Kinugasa‐Katayama, Nobuyuki Takakura · 2015 · Advanced Drug Delivery Reviews
  89. Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
    Aykut, Berk, Chen, Ruonan, Kim, Jacqueline I., Wu, Dongling, Shadaloey, Sorin A. A., Abengozar, Raquel, Preiss, Pamela, Saxena, Anjana, Pushalkar, Smruti, Leinwand, Joshua et al. · 2020 · Science Immunology
  90. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis
    Yu Zhang, Celestia Davis, Sapana N. Shah, Daniel Titus Hughes, James C. Ryan, Diego Altomare, Maria Marjorette O. Peña · 2016 · Molecular Carcinogenesis
  91. Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss
    Lee Ann Jolly, Sergey V. Novitskiy, Philip Owens, Nicole A. Massoll, Nikki Cheng, Wei Bin Fang, Harold L. Moses, Aime T. Franco · 2016 · Cancer Research
  92. A Listeria Vaccine and Depletion of T-Regulatory Cells Activate Immunity Against Early Stage Pancreatic Intraepithelial Neoplasms and Prolong Survival of Mice
    Bridget P. Keenan, Yvonne M. Saenger, Michel I. Kafrouni, Ashley Leubner, Peter Lauer, Anirban Maitra, Agnieszka A. Rucki, Andrew J. Gunderson, Lisa M. Coussens, Dirk G. Brockstedt et al. · 2014 · Gastroenterology
  93. Interleukin-6 in inflammatory and malignant diseases of the pancreas
    Marina Lesina, Sonja M. Wörmann, Patrick Neuhöfer, Liang Song, Hana Algül · 2014 · Seminars in Immunology
  94. IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
    Richard P. Tobin, Kimberly Rae Jordan, Puja Kapoor, Eric Spongberg, Dana M. Davis, Victoria M. Vorwald, Kasey L. Couts, Dexiang Gao, Derek E. Smith, Jessica S.W. Borgers et al. · 2019 · Frontiers in Oncology
  95. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling
    Barath Udayasuryan, Raffae N. Ahmad, Tam T. D. Nguyen, Ariana Umaña, LaDeidra Monét Roberts, Polina Sobol, Stephen D. Jones, Jennifer M. Munson, Daniel Joseph Slade, Scott S. Verbridge · 2022 · Science Signaling
  96. Vascular permeability changes involved in tumor metastasis
    Jonathan García-Román, Alejandro Zentella‐Dehesa · 2013 · Cancer Letters
  97. SPARC independent drug delivery and antitumour effects of nab -paclitaxel in genetically engineered mice
    Albrecht Neeße, Kristopher K. Frese, Derek S. Chan, Tashinga E. Bapiro, William Howat, Frances M. Richards, Volker Ellenrieder, Duncan Ian Jodrell, David A. Tuveson · 2013 · Gut
  98. Genetically Engineered Mouse Models of Pancreatic Cancer
    Christoph Benedikt Westphalen, Kenneth P. Olive · 2012 · The Cancer Journal
  99. Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue
    Yu Si, Simon F. Merz, Philipp Jansen, Bao-Xiao Wang, Kirsten Bruderek, Petra Altenhoff, Stefan Mattheis, Stephan Lang, Matthias Gunzer, Joachim Klode et al. · 2019 · Science Immunology
  100. miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis
    Nada Sonda, Francesca Simonato, Elisa Peranzoni, Bianca Calì, Stefania Bortoluzzi, Andrea Bisognin, Ena Wang, Francesco Maria Marincola, Luigi Naldini, Bernhard Gentner et al. · 2013 · Immunity